Cantor Fitzgerald analyst Steven Halper calls the claims made by Aurelius Value against Health Insurance Innovations "unfounded." The stock in afternoon trading is down 8%, or $2.52, to $30.02. The Federal Trade Commission document used by the short seller may have been taken out of context from the ongoing legal process between the agency and Simple Health, Halper tells investors in a research note. The analyst points out Health Insurance Innovations ended its relationship with Simple in early November after the FTC issued a restraining order against the company. Halper says he was "fully aware" that Health Insurance Innovations continues to be paid for policies in force prior to the shut down of Simple Health. His understanding was that the restraining order prevented Simple Health to sell new policies. The analyst does not believe Health Insurance is in a position to cancel these policies, "but obviously consumers can," he writes. There should be no impact on revenue in 2019 from this issue as the company recognizes the estimated life time value of the plan when the plan is sold, Halper contends. The analyst finds Health Insurance Innovations "very inexpensive at current levels" and keeps an Overweight rating on the name with a $75 price target.